Deutsche Bank
NGM

Deutsche Bank’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Deutsche Bank’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-212,944
Closed -$183K – 3693
2023
Q4 		$183K Buy
+212,944
New +$187K ﹤0.01% 2932
2023
Q3 		– Sell
-231,917
Closed -$601K – 3868
2023
Q2 		$601K Sell
231,917
-6,599
-3% -$23.5K ﹤0.01% 2258
2023
Q1 		$973K Sell
238,516
-5,339
-2% -$24.7K ﹤0.01% 2121
2022
Q4 		$1.22M Sell
243,855
-18,996
-7% -$119K ﹤0.01% 1925
2022
Q3 		$3.44M Sell
262,851
-1,061
-0.4% -$16.1K ﹤0.01% 1365
2022
Q2 		$3.38M Buy
263,912
+92,018
+54% +$1.27M ﹤0.01% 1482
2022
Q1 		$2.62M Buy
171,894
+3,650
+2% +$56.9K ﹤0.01% 1735
2021
Q4 		$2.98M Sell
168,244
-7,991
-5% -$153K ﹤0.01% 1749
2021
Q3 		$3.71M Buy
176,235
+23,381
+15% +$515K ﹤0.01% 1692
2021
Q2 		$3.01M Sell
152,854
-111,848
-42% -$2.62M ﹤0.01% 1870
2021
Q1 		$7.69M Buy
264,702
+246,926
+1,389% +$6.91M ﹤0.01% 1323
2020
Q4 		$539K Buy
17,776
+4,786
+37% +$105K ﹤0.01% 2857
2020
Q3 		$207K Buy
12,990
+1,136
+10% +$20.7K ﹤0.01% 3195
2020
Q2 		$234K Buy
11,854
+2,057
+21% +$39.3K ﹤0.01% 3064
2020
Q1 		$121K Buy
9,797
+819
+9% +$13.4K ﹤0.01% 3171
2019
Q4 		$165K Buy
8,978
+6,955
+344% +$102K ﹤0.01% 3339
2019
Q3 		$26K Sell
2,023
-1,366
-40% -$20.5K ﹤0.01% 4231
2019
Q2 		$49K Buy
+3,389
New +$49.6K ﹤0.01% 4518

Other funds holding NGM

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank's NGM Position: Q1 2024 in Review

Deutsche Bank sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q1 2024, closing a stake of 212,944 shares — an estimated $183K sold.

Deutsche Bank first reported a position in NGM in Q2 2019 and held it in 18 quarters. The position peaked at $7.69M in Q1 2021. 75 funds tracked by Wall St. Rank hold NGM as of Q1 2024.

  • Deutsche Bank reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Deutsche Bank sold 212,944 NGM Biopharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $183K.
  • Deutsche Bank first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
  • Deutsche Bank's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $7.69M in Q1 2021.
  • 75 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Deutsche Bank's 13F filing for Q1 2024, filed 15 May 2024.